BioRestorative Therapies (BRTX) Leases (2019 - 2024)
BioRestorative Therapies (BRTX) has disclosed Leases for 8 consecutive years, with $39697.0 as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Leases fell 74.34% year-over-year to $39697.0, compared with a TTM value of $39697.0 through Sep 2024, down 74.34%, and an annual FY2023 reading of $151447.0, down 37.36% over the prior year.
- Leases was $39697.0 for Q3 2024 at BioRestorative Therapies, down from $78146.0 in the prior quarter.
- Across five years, Leases topped out at $560883.0 in Q1 2020 and bottomed at $39697.0 in Q3 2024.
- Average Leases over 5 years is $302723.6, with a median of $299783.0 recorded in 2022.
- The sharpest move saw Leases decreased 19.67% in 2020, then tumbled 74.34% in 2024.
- Year by year, Leases stood at $473849.0 in 2020, then fell by 24.49% to $357805.0 in 2021, then plummeted by 32.43% to $241760.0 in 2022, then crashed by 37.36% to $151447.0 in 2023, then crashed by 73.79% to $39697.0 in 2024.
- Business Quant data shows Leases for BRTX at $39697.0 in Q3 2024, $78146.0 in Q2 2024, and $115385.0 in Q1 2024.